Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Immunopharmacol ; 17(3): 593-600, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23954198

RESUMO

Novel lipidated analogs of iridoids viz., Agnuside and Negundoside with different chain length were synthesized and tested for immune adjuvant activity in the presence of weak antigen ovalbumin. Based on in vitro assay, 6-O-palmitoyl Agnuside (AG-3) was further taken up for detailed in vivo activity and found to significantly enhance the production of anti OVA IgG titer, neutralizing antibody (IgG1 and IgG2a) titer as well as soluble mediators of a Th1 (IL-2, IFN-γ)/Th2 response (IL-4) and proliferation of T lymphocyte subsets (CD4/CD8) and co stimulatory molecules CD80/CD86. Furthermore, the SAR studies revealed that presence of acyl group at aglycon moiety of these iridoid glycosides is crucial for immune adjuvant activity.


Assuntos
Adjuvantes Imunológicos/farmacologia , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD8-Positivos/efeitos dos fármacos , Glucosídeos/farmacologia , Glicosídeos Iridoides/farmacologia , Adjuvantes Imunológicos/síntese química , Animais , Antígenos/imunologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Proliferação de Células/efeitos dos fármacos , Citocinas/sangue , Glucosídeos/síntese química , Imunoglobulina G/sangue , Glicosídeos Iridoides/síntese química , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Ovalbumina/imunologia , Baço/citologia , Subpopulações de Linfócitos T/efeitos dos fármacos , Subpopulações de Linfócitos T/imunologia
2.
Eur J Med Chem ; 46(8): 3210-7, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21620534

RESUMO

Several novel spiro derivatives of parthenin (1) have been synthesized by the dipolar cycloaddition using various dipoles viz; benzonitrile oxides, nitrones and azides with exocyclic double bond of C ring (α-methylene-γ-butyrolactone). Majority of the compounds exhibited improved anti-cancer activity compared to the parthenin, when screened for their in vitro cytotoxicity against three human cancer cell lines viz., SW-620, DU-145 and PC-3. In vivo screening of select analog revealed improved anti-cancer activity with low mammalian toxicity as compared to parthenin. The results of the cytotoxicity pattern of these derivatives reveals the SAR of these sesquiterpinoid lactones and possible role of α,ß-unsaturated ketone of parthenin in inhibiting NF-kB. A mechanistic correlation of anti-cancer activity along with in vivo and western blotting experiments has been described.


Assuntos
Antineoplásicos/síntese química , Carcinoma de Ehrlich/tratamento farmacológico , Proliferação de Células/efeitos dos fármacos , Fragmentação do DNA/efeitos dos fármacos , NF-kappa B/antagonistas & inibidores , Sesquiterpenos/síntese química , Compostos de Espiro/síntese química , 4-Butirolactona/análogos & derivados , 4-Butirolactona/química , Animais , Antineoplásicos/farmacologia , Western Blotting , Carcinoma de Ehrlich/patologia , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/patologia , Humanos , Masculino , Camundongos , NF-kappa B/metabolismo , Transplante de Neoplasias , Nitrilas/química , Óxidos/química , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/patologia , Sesquiterpenos/farmacologia , Compostos de Espiro/farmacologia , Relação Estrutura-Atividade
3.
Chem Biodivers ; 5(9): 1792-802, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18816530

RESUMO

A series of novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin derivatives were synthesized by employing Cu(I)-catalyzed click chemistry and evaluated for their anticancer activity against a panel of seven human cancer cell lines (HT-29, HCT-15, 502713, HOP-62, A-549, MCF-7, and SF-295). The compounds 9b, 9c, 9e, 9f, and 9h showed significant cytotoxic activities especially against HT-29, HCT-15, 502713 cell lines.


Assuntos
Antineoplásicos/síntese química , Antineoplásicos/farmacologia , Podofilotoxina/síntese química , Podofilotoxina/farmacologia , Triazóis/química , Antineoplásicos/química , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Estrutura Molecular , Podofilotoxina/química , Relação Estrutura-Atividade
4.
Acta Pol Pharm ; 64(1): 27-33, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17665847

RESUMO

Four new ethylnitrosourea derivatives of substituted naphthalimides 3a-d have been synthesized from the respective N-(2-ethylamino) naphthalimides. Their chemical alkylating activity compared with the clinical drug CCNU and an experimental compound Mitonafide indicated that they possess lower alkylating activity than CCNU and comparable activity with the latter. Their anti-tumor efficacies were assessed in vivo in two murine ascites tumors namely Sarcoma-180 (S-180) and Ehrlich ascites carcinoma (EAC) by measuring the increase in median survival times (MST) of drug treated (T) over untreated control (C) mice. CCNU and Mitonafide were used as positive controls for comparison. The representative compound 3a has displayed marginal anti-tumoral activity in these tumors. Three compounds were further screened in vitro in 4 different human tumor cell lines but no significant activity was observed in those lines. These compounds moderately inhibit the synthesis of DNA and RNA in S-180 tumor cells.


Assuntos
Antineoplásicos Alquilantes/síntese química , Carcinoma de Ehrlich/tratamento farmacológico , Naftalimidas/síntese química , Compostos de Nitrosoureia/síntese química , Sarcoma 180/tratamento farmacológico , Animais , Antineoplásicos Alquilantes/química , Antineoplásicos Alquilantes/farmacologia , Linhagem Celular Tumoral , DNA/biossíntese , DNA/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Imidas/farmacologia , Isoquinolinas/farmacologia , Lomustina/farmacologia , Camundongos , Naftalimidas/química , Naftalimidas/farmacologia , Compostos de Nitrosoureia/administração & dosagem , Compostos de Nitrosoureia/química , Compostos de Nitrosoureia/farmacologia , RNA/biossíntese , RNA/efeitos dos fármacos , Relação Estrutura-Atividade
5.
Phytochemistry ; 67(20): 2269-76, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16956635

RESUMO

The main active components and genetic profile of 15 selected accessions of Withania somnifera Dunal. were analysed. Ethanolic extract of the dried roots/leaves of the plant was concentrated under pressure at 50+/-5 degrees C and was analysed for main compounds (withanolides and withaferin A) by HPLC. All the main components were found to be present in accessions (AGB 002, AGB 009, RSS 009, RSS 033). Correlation of these main components with their genetic factors, was undertaken using AFLP (amplified fragment length polymorphism) markers. Among 64 primers 7 yielded optimum polymorphism. A total of 913 polymorphic peaks were generated using these primers. Jaccard's similarity coefficient indicated that accessions having almost the same active compounds clustered together. The present study demonstrates that AFLP can be successfully used to resolve the correlation of AFLP data with the presence of secondary metabolites.


Assuntos
Withania/química , Cromatografia Líquida de Alta Pressão , Impressões Digitais de DNA , Marcadores Genéticos , Extratos Vegetais/química , Folhas de Planta/química , Folhas de Planta/genética , Raízes de Plantas/química , Raízes de Plantas/genética , Polimorfismo Genético , Withania/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...